Home › Funds › Kinsale Capital Group, Inc. › JNJ

Kinsale Capital Group, Inc. position in JNJ

JOHNSON JOHNSON · Health Care

Kinsale Capital Group, Inc. reported holding 84,464 shares of JNJ (JOHNSON JOHNSON) in its Q2 2026 13F filing — a position valued at US$21.5M, representing 2.84% of its reported portfolio and ranking #3 among its reported holdings. Kinsale Capital Group, Inc. has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)84.46K sh
Reported value held$21.45M
Portfolio Weight2.84%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Kinsale Capital Group, Inc.'s JNJ position evolved

Kinsale Capital Group, Inc. first disclosed a stake in JNJ in Q3 2023 at 18,157 shares (US$2.8M). The position peaked in Q2 2026 at 84,464 shares, worth US$21.5M. Across 12 filings, Kinsale Capital Group, Inc. increased the stake 11 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 84,464 shares valued at US$21.5M — an increase of 7,462 shares quarter over quarter.. Notable position changes include a 36% increase in Q4 2023 (shares rose 1% over the following quarter), a 27% increase in Q2 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 18.16K $2.83M New
Q4 2023 24.74K $3.88M Add
Q1 2024 29.92K $4.73M Add
Q2 2024 37.87K $5.54M Add
Q3 2024 44.25K $7.17M Add
Q4 2024 50.67K $7.33M Add
Q1 2025 58.33K $9.67M Add
Q2 2025 65.13K $9.95M Add
Q3 2025 70.84K $13.14M Add
Q4 2025 73.76K $15.27M Add
Q1 2026 77.00K $18.82M Add
Q2 2026 84.46K $21.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Kinsale Capital Group, Inc. held JNJ?

Kinsale Capital Group, Inc. has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Kinsale Capital Group, Inc.'s current position in JNJ?

As of Q2 2026, Kinsale Capital Group, Inc. holds 84.46K shares of JNJ (JOHNSON JOHNSON), valued at $21.45M, representing 2.84% of its reported portfolio and ranking #3.

Has Kinsale Capital Group, Inc. been buying or selling JNJ?

In the latest 13F filing (Q2 2026), Kinsale Capital Group, Inc. increased its position in JNJ. The position peaked in Q2 2026 at 84.46K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.